York University researchers say a simple test that combines thinking and movement can help to detect heightened risk for developing Alzheimer’s disease in a person, even before there are any telltale behavioural signs of dementia.
Faculty of Health Professor Lauren Sergio and PhD candidate Kara Hawkins who led the study asked the participants to complete four increasingly demanding visual-spatial and cognitive-motor tasks, on dual screen laptop computers. The test aimed at detecting the tendency for Alzheimer’s in those who were having cognitive difficulty even though they were not showing outward signs of the disease.
“We included a task which involved moving a computer mouse in the opposite direction of a visual target on the screen, requiring the person’s brain to think before and during their hand movements,” says Sergio in the School of Kinesiology & Health Science. “This is where we found the most pronounced difference between those with mild cognitive impairment (MCI) and family history group and the two control groups.”
Hawkins adds, “We know that really well-learned, stereotyped motor behaviours are preserved until very late in Alzheimer’s disease.” These include routine movements, such as walking. The disruption in communication will be evident when movements require the person to think about what it is they are trying to do.
For the test, the participants were divided into three groups – those diagnosed with MCI or had a family history of Alzheimer’s disease, and two control groups, young adults and older adults, without a family history of the disease.
The Latest on: Alzheimers detection
[google_news title=”” keyword=”Alzheimers detection” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Alzheimers detection
- Walk to End Alzheimer’s dates announcedon May 17, 2024 at 5:50 am
The Alzheimer’s Association Miami Valley Chapter has announced the dates and locations for five local 2024 Walk to End Alzheimer’s, the world’s largest event to raise awareness and funds for Alzheimer ...
- Breakthrough Alzheimer's Treatment Featured In New Boomers Today Podcast Episodeon May 16, 2024 at 10:57 am
Petaluma, California - Boomers Today, a podcast hosted by Frank Samson, CEO and Founder of Senior Care Authority, has released a groundbreaking ...
- Pharma company raises millions to fund Alzheimer's, cardiovascular drug researchon May 16, 2024 at 10:25 am
The drug is being tested as a potential treatment for Alzheimer's disease and hypoplastic left heart syndrome, a pediatric disease that affects normal blood flow through the heart.
- Climate change may worsen stroke, migraine, Alzheimer'son May 16, 2024 at 9:48 am
Climate change is likely to make brain conditions like stroke, migraine, Alzheimer's disease, epilepsy and multiple sclerosis ... a move that could increase early detection in those at risk for ...
- Researchers discover new biomarker to diagnose Alzheimer's in asymptomatic stageson May 16, 2024 at 3:43 am
The hunt for stable, readily observable biomarkers in biofluids, such microRNAs, presents a chance to identify Alzheimer's early on when the disease is asymptomatic. This condition, which affects over ...
- Alzheimer's Newson May 15, 2024 at 5:00 pm
Research Sheds Light on How Proteins Linked to Alzheimer's Disease Influence Neuronal Growth May 15, 2024 — New research has shed light in the complex interplay between cell proteins ...
- New biomarker identified to diagnose Alzheimer's in asymptomatic stageson May 15, 2024 at 8:32 am
The search for biomarkers that are stable and easily detectable in biofluids, such as microRNAs, offers hope for detecting Alzheimer's disease in its early, asymptomatic stages. Early detection could ...
- Multiple studies of Alzheimer’s bring new pathways for treatmenton May 15, 2024 at 8:22 am
Alzheimer’s cases are on the rise in the U.S., but an abundance of new drugs is helping millions fight the disease, including thousands of Georgians who are benefitting from the rapid surge in early ...
- New biomarker for asymptomatic stages of Alzheimer’s diseaseon May 15, 2024 at 6:31 am
Researchers identified miR-519a-3p as a biomarker that could enable early diagnosis and treatment of neurodegenerative diseases.
- New biomarker to diagnose Alzheimer's in asymptomatic stageson May 14, 2024 at 5:00 pm
This is a molecule that is directly linked to the expression of the cellular prion protein found on the surface of nerve cells. The study, led by the Institute for Bioengineering of Catalonia, opens ...
via Bing News